Polypectomy Clinical Trial
Colonoscopy has been shown to reduce the incidence and mortality of colorectal cancer,
through the recognition and removal of pre-cancerous lesions, which in most cases evolve
with a sequence that goes through formation of high-grade dysplasia (HGD).
The probability of HGD increases with the increase of the lesion of the polyp itself.
Lesions> 2 cm are present in 1% of colonoscopy screening. The resection of these lesions
presents a greater technical difficulty and consequently a decrease in the efficiency. The
rate of incomplete resection reported in the literature reaches 10% while that of recurrence
/ residual adenoma 16.4 / 31.7%.
The aim of the study SCALP is to evaluate the incidence of complications, efficacy and cost
of endoscopic resection of colic lesions> 2cm in a setting of clinical practice in an
unselected population
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01647581 -
Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping
|
N/A | |
| Completed |
NCT05273697 -
Clinical Study to Compare Cold Snare Underwater Polypectomy to Cold Snare Conventional Polypectomy for Colon Polyps [COLDWATER Study]
|
N/A | |
| Completed |
NCT02188316 -
Comparison of Jumbo and Hot Biopsy Forceps
|
N/A | |
| Terminated |
NCT02641509 -
Accuracy in Resection of Non-pedunculated Colonic Lesions 5-20 mm With/Without Using NBI
|
N/A |